Literature DB >> 7921613

The effect of 5-HT1A receptor agonists on locomotor activity in the guinea-pig.

J L Evenden1.   

Abstract

1. The present study examined the effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, ipsapirone and buspirone, all agonists at the 5-HT1A receptor, on the locomotor activity of guinea-pigs. The effects of these drugs were contrasted with those of the non-selective 5-HT agonist, 5-methoxy-N,N-dimethyl tryptamine (5-MeO-DMT) and the dopamine D2 antagonist, raclopride. 2. 8-OH-DPAT, flesinoxan and 5-MeO-DMT markedly increased the locomotor activity of naive, unhabituated guinea-pigs in a dose-dependent manner. Buspirone also did so, although to a lesser extent and for a shorter time. The doses at which this effect was seen were higher than those normally employed in rats. Ipsapirone and raclopride had no significant effects on locomotor activity. 3. The locomotor activity increasing effect of 1.0 mg kg-1 8-OH-DPAT was blocked by the selective 5-HT1A antagonist (S)-UH-301 (3.0 and 10.0 mg kg-1), but not by (-)-alprenolol (15.0 mg kg-1). Ipsapirone (30.0 mg kg-1) and raclopride (3.0 mg kg-1) antagonized 8-OH-DPAT-induced locomotor activity but only to a small extent. The 5-HT reuptake inhibitor, zimelidine (10.0 mg kg-1) had no effect. 4. The effect of the 5-HT1A agonists in the guinea-pig contrasts with the effects of 8-OH-DPAT on the locomotor activity of unhabituated rats and mice tested in the same apparatus, but are similar to the effects of 8-OH-DPAT on habituated rats, which show a low baseline of activity. 5. These results support the suggestion that 5-HTIA agonists may have an intrinsic activating effect which may be masked by other effects of the drug (e.g. hypothermia, 5-HT syndrome). The rank ordering of the 5-HTIA agonists also suggests that the degree to which the drugs increase locomotor activity is related to their agonist efficacy at the postsynaptic 5-HTIA receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7921613      PMCID: PMC1910217          DOI: 10.1111/j.1476-5381.1994.tb13159.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain.

Authors:  D Hoyer; D N Middlemiss
Journal:  Trends Pharmacol Sci       Date:  1989-04       Impact factor: 14.819

2.  Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-02       Impact factor: 4.436

3.  Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.

Authors:  C Köhler; H Hall; S O Ogren; L Gawell
Journal:  Biochem Pharmacol       Date:  1985-07-01       Impact factor: 5.858

4.  Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens.

Authors:  S M Mittman; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

6.  Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after repeated administration on a conditioned avoidance response (CAR) in the rat.

Authors:  J L Evenden
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.

Authors:  P Schoeffter; D Hoyer
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

8.  Effects of 8-OH-DPAT on motor activity in the rat.

Authors:  V Hillegaart; M L Wadenberg; S Ahlenius
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

9.  1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.

Authors:  S Caccia; I Conti; G Viganò; S Garattini
Journal:  Pharmacology       Date:  1986       Impact factor: 2.547

10.  The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.

Authors:  J Yamada; Y Sugimoto; K Horisaka
Journal:  Eur J Pharmacol       Date:  1988-09-23       Impact factor: 4.432

View more
  2 in total

1.  Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.

Authors:  Aaron Ettenberg; Rick E Bernardi
Journal:  Pharmacol Biochem Behav       Date:  2006-10-24       Impact factor: 3.533

Review 2.  A narrative synthesis of research with 5-MeO-DMT.

Authors:  Anna O Ermakova; Fiona Dunbar; James Rucker; Matthew W Johnson
Journal:  J Psychopharmacol       Date:  2021-10-19       Impact factor: 4.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.